基本信息
浏览量:46
职业迁徙
个人简介
My lab studies the role of natural killer (NK) cells in mediating immunity against glioblastoma as well as other solid tumors and seeks to understand the mechanisms of tumor-induced NK cell dysfunction. The goal of my research is to develop strategies for genetically engineering NK cells to enhance their in vivo anti-tumor activity and persistence. My laboratory has extensive experience in multi-parameter flow cytometry, CyTOF, xenogenic NSG mouse models of human cancer and various molecular biology techniques. I lead the NK immunotherapy program at MD Anderson and translate multiple innovative strategies from bench to bedside, including a first-in-human trial of CAR NK cells in patients with lymphoid malignancies.
研究兴趣
论文共 121 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
引用1浏览0WOSNATURE引用
1
0
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 2546-2546
引用0浏览0引用
0
0
SSRN Electronic Journal (2022)
Journal of Clinical Oncologyno. 4 (2022): TPS633-TPS633
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn